Viewing Study NCT01508702


Ignite Creation Date: 2025-12-25 @ 3:46 AM
Ignite Modification Date: 2026-07-14 @ 12:17 AM
Study NCT ID: NCT01508702
Status: COMPLETED
Last Update Posted: 2016-02-12
First Post: 2012-01-10
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
Sponsor: Ardea Biosciences, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Gout View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Gout View